Optum Rx to Modernize Pharmacy Payment Models Rising drug prices set by pharmaceutical manufacturers are placing significant financial strain on pharmacies across the United States. As the cost of prescription drugs increases, many pharmacies struggle to maintain high-quality patient care.…
ICON Fully Integrates Medidata Clinical Data Studio Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions for the life sciences industry, has announced a significant partnership with ICON plc, a globally recognized clinical research organization (CRO)…
Faeth Therapeutics & GOG-F Launch Phase 2 Trial for Sapanisertib-Serabelisib in Endometrial Cancer Faeth Therapeutics (Faeth), a clinical-stage biotechnology company dedicated to pioneering novel metabolism-based therapeutic strategies, and The GOG Foundation, Inc. (GOG-F), a not-for-profit organization committed to advancing the…
City of Hope’s Phase 1 Trial Featured at SSO Annual Meeting City of Hope’s groundbreaking Phase 1 clinical trial has demonstrated promising results for patients suffering from colorectal and appendiceal cancer that has metastasized to the peritoneum. As one of…
LGM Pharma Invests $6 Million to Expand U.S. Drug Manufacturing Capabilities LGM Pharma, a leading provider of tailored active pharmaceutical ingredient (API) and contract development and manufacturing organization (CDMO) services, has announced a significant investment of over $6 million to…
Tenpoint Therapeutics Names Carol Kearney as Chief Commercial Officer Tenpoint Therapeutics Ltd. (“Tenpoint”), a global, clinical-stage biotechnology company dedicated to pioneering treatments that rejuvenate vision in the aging eye, has announced the appointment of Carol Kearney as Chief Commercial Officer…
Noramco Group Invests $25M in Halo Pharma for Sterile Injectables The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Establish Sterile Injectable Manufacturing The Noramco Group, a fully integrated North American-based supplier of active pharmaceutical ingredients (APIs)…
ZYUS Life Sciences Closes Unsecured Loan and Amends Previous Loans ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company focused on the research, development, and commercialization of innovative cannabinoid-based pharmaceutical drug candidates for pain…
Frazier Life Sciences Names Gerald Nepom as Senior Advisor Frazier Life Sciences (FLS), a premier investment firm dedicated to advancing groundbreaking therapeutics, has appointed Gerald (Jerry) Nepom, M.D., Ph.D., as Senior Advisor. This strategic addition brings an esteemed expert in…
Xeris Biopharma Reports Record Q4 and Full-Year 2024 Results, Sets 2025 Guidance Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a rapidly growing biopharmaceutical company dedicated to improving patient lives by developing and commercializing innovative therapies, has announced record-breaking financial results for…
Italfarmaco Updates on Givinostat for Duchenne Muscular Dystrophy Italfarmaco S.p.A., a global pharmaceutical company dedicated to developing innovative treatments for rare diseases, has provided a comprehensive update on the regulatory and clinical advancements of givinostat, its investigational therapy for Duchenne…
Alnylam Announces Retirement of Co-Founder and Esteemed Board Member Dr. Phillip A. Sharp Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the pioneering leader in RNA interference (RNAi) therapeutics, today announced the retirement of Dr. Phillip A. Sharp, Ph.D., from the Company’s Board…